Comparative Proteomics Identifies Host Immune System Proteins Affected by Infection with Mycobacterium bovis

PLoS Neglected Tropical Diseases

Volumn 10, Issue 3, 2016, Pages

  López, Vladimir ^a   Villar, Margarita ^a   Queirós, João ^a,b,c   Vicente, Joaquín ^a   Mateos Hernández, Lourdes ^a   Díez Delgado, Iratxe ^a,d   Contreras, Marinela ^a   Alves, Paulo C ^b,c,e   Alberdi, Pilar ^a   Gortázar, Christian ^a   de la Fuente, José ^a,f  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b CENTRO DE INVESTIGAÇÃO EM BIODIVERSIDADE E RECURSOS GENÉTICOS   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e UNIVERSITY OF MONTANA   (United States)

^f OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CATHELICIDIN; HEME PEROXIDASE; HEMOGLOBIN; LACTOFERRIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDOGLYCAN RECOGNITION PROTEIN; PEROXIDASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BOVINE TUBERCULOSIS; DISEASE TRANSMISSION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; LYMPH NODE; METABOLISM; MYCOBACTERIUM BOVIS; PIG; SWINE DISEASE; TUBERCULOSIS; VETERINARY;

ANIMALS; GENE EXPRESSION REGULATION; HEMOGLOBINS; HUMANS; LYMPH NODES; MYCOBACTERIUM BOVIS; PROTEOMICS; SUS SCROFA; SWINE; SWINE DISEASES; TUBERCULOSIS;

EID: 84962362099     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004541     Document Type: Article

References (44)

1. World Health Organization. Tuberculosis. Fact sheet N°104. Updated October 2015. Available: http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed 3 February 2016.
2. Gortazar C, Torres MJ, Acevedo P, Aznar J, Negro JJ, De La Fuente J, et al. Fine-tuning the space, time, and host distribution of mycobacteria in wildlife. BMC Microbiol. 2011;11:27. doi: 10.1186/1471-2180-11-2721288321
3. Gortazar C, Delahay RJ, McDonald RA, Boadella M, Wilson GJ, Gavier-Widen D, et al. The status of tuberculosis in European wild mammals. Mamm Rev. 2012;42:193–206.
4. Rodríguez E, Sánchez LP, Pérez S, Herrera L, Jiménez MS, Samper S, et al. Human tuberculosis due to Mycobacterium bovis and M. caprae in Spain, 2004–2007. Int J Tuberc Lung Dis. 2009;13(12):1536–41. 19919773
5. Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, Morlock GP, et al. Human tuberculosis due to Mycobacterium bovis in the United States, 1995–2005. Clin Infect Dis. 2008;47:168–75. doi: 10.1086/58924018532886
6. Ryan TJ, Livingstone PG, Ramsey DSL, De Lisle GW, Nugent G, Collins DM, et al. Advances in understanding disease epidemiology and implications for control and eradication of tuberculosis in livestock: The experience from New Zealand. Vet Microbiol. 2006;112:211–9. 16330161
7. Naranjo V, Gortazar C, Vicente J, de la Fuente J, Evidence of the role of European wild boar as a reservoir of Mycobacterium tuberculosis complex. Vet Microbiol. 2008;127:1–9. 18023299
8. Garrido JM, Sevilla IA, Beltrán-Beck B, Minguijón E, Ballesteros C, Galindo RC, et al. Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis. PLoS ONE. 2011;6(9):e24905. doi: 10.1371/journal.pone.002490521935486
9. Beltrán-Beck B, de la Fuente J, Garrido JM, Aranaz A, Sevilla I, Villar M, et al. Oral vaccination with heat inactivated Mycobacterium bovis activates the complement system to protect against tuberculosis. PLoS ONE. 2014;9(5): e98048. doi: 10.1371/journal.pone.009804824842853
10. Bolin CA, Whipple DL, Khanna KV, Risdahl JM, Peterson PK, Molitor TW, Infection of swine with Mycobacterium bovis as a model of human tuberculosis. J Infect Dis. 1997;176: 1559–66. 9395368
11. Russell DG, Who puts the tubercle in tuberculosis?Nat Rev Microbiol. 2007;5:39–47. 17160001
12. Martín-Hernando MP, Höfle U, Vicente J, Ruiz-Fons F, Vidal D, Barral M, et al. Lesions associated with Mycobacterium tuberculosis complex infection in the European wild boar. Tuberculosis2007;87: 360–67. 17395539
13. Barasona JA, Torres MJ, Aznar J, Gortázar C, Vicente J, DNA detection reveals Mycobacterium tuberculosis complex shedding routes in its wildlife reservoir the Eurasian wild boar. Transbound Emerg Dis. 2016, in press. doi: 10.1111/tbed.12458
14. Naranjo V, Höfle U, Vicente J, et al. Genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of tuberculous and nontuberculous European wild boars naturally exposed to Mycobacterium bovis. FEMS Immunol Med Microbiol. 2006; 46: 298–312. 16487312
15. Naranjo V, Ayoubi P, Vicente J, Martín MP, Ruiz-Fons F, Gortazar C, et al. Characterization of selected genes upregulated in non-tuberculous European wild boar as possible correlates of resistance to Mycobacterium bovis infection. Vet Microbiol. 2006; 116: 224–31. 16672181
16. Naranjo V., Acevedo-Whitehouse A., Vicente J., Gortazar C., de la Fuente J., Influence of methylmalonyl-CoA mutase alleles on resistance to bovine tuberculosis in the European wild boar (Sus scrofa). Anim Genet. 2008; 39: 316–20. doi: 10.1111/j.1365-2052.2008.01725.x18454807
17. Saez-Royuela C, Gomariz RP, Telleria JL, Age determination of European wild boar. Wildl Soc Bull. 1989; 17:326–9.
18. Vicente J, Barasona JA, Acevedo P, Ruiz-Fons JF, Boadella M, Diez-Delgado I, et al. Temporal trend of tuberculosis in wild ungulates from mediterranean Spain. Transbound Emerg Dis. 2013; 60(suppl. 1):92–103. doi: 10.1111/tbed.1216724171854
19. Ballesteros C, Garrido JM, Vicente J, Romero B, Galindo RC, Minguijón E, et al. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain. Vaccine. 2009;27:6662–8. doi: 10.1016/j.vaccine.2009.08.09519747578
20. Villar M, Popara M, Mangold AJ, de la Fuente J, Comparative proteomics for the characterization of the most relevant Amblyomma tick species as vectors of zoonotic pathogens worldwide. J Proteomics. 2014; 105: 204–16. doi: 10.1016/j.jprot.2013.12.01624382551
21. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M, In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2006; 1: 2856–60. 17406544
22. Almazán C, Lagunes R, Villar M, Canales M, Rosario-Cruz R, Jongejan F, et al. Identification and characterization of Rhipicephalus (Boophilus) microplus candidate protective antigens for the control of cattle tick infestations. Parasitol Res. 2010; 106:471–9. doi: 10.1007/s00436-009-1689-119943063
23. Gortazar C, Vicente J, Samper S, Garrido J, Fernández de Mera IG, Gavín P, et al. Molecular characterization of Mycobacterium tuberculosis complex isolates from wild ungulates in South-Central Spain. Vet Res. 2005; 36: 43–52. 15610722
24. de la Fuente J, Díez-Delgado I, Contreras M, Vicente J, Cabezas-Cruz A, Tobes R, et al. Comparative genomics of field isolates of Mycobacterium bovis and M. caprae provides evidence for possible correlates with bacterial viability and virulence. PLoS Negl Trop Dis. 2015; 9: e0004232. doi: 10.1371/journal.pntd.000423226583774
25. Schiopu A, Cotoi OS, S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. Mediators Inflamm. 2013;2013:828354. doi: 10.1155/2013/82835424453429
26. Behar SM, Divangahi M, Remold HG, Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?Nature. 2010; 8: 668–74.
27. Gopal R, Monin L, Torres D, Slight S, Mehra S, McKenna KC, et al. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. Am J Respir Crit Care Med. 2013;188: 1137–46. doi: 10.1164/rccm.201304-0803OC24047412
28. Farhana A, Saini V, Kumar A, Lancaster JR, JrSteyn AJ, Environmental heme-based sensor proteins: implications for understanding bacterial pathogenesis. Antioxid Redox Signal. 2012; 17:1232–45. doi: 10.1089/ars.2012.461322494151
29. Borelli V, Vita F, Shankar S, Soranzo MR, Banfi E, et al. Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis. Infect Immun. 2003; 71: 605–13. 12540536
30. Jones CM, Niederweis M, Mycobacterium tuberculosis can utilize heme as an iron source. J Bacteriol. 2011; 193: 1767–70. doi: 10.1128/JB.01312-1021296960
31. Olakanmi O, Kesavalu B, Abdalla MY, Britigan BE, Iron acquisition by Mycobacterium tuberculosis residing within myeloid dendritic cells. Microb Pathog. 2013; 65:21–8. doi: 10.1016/j.micpath.2013.09.00224067451
32. Thom RE, Elmore MJ, Williams A, Andrews SC, Drobniewski F, Marsh PD, et al. The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis challenge. Vaccine. 2012; 30: 3159–68. doi: 10.1016/j.vaccine.2012.03.00822426328
33. Johnson EE, Wessling-Resnick M, Iron metabolism and the innate immune response to infection. Microbes Infect. 2012; 14: 207–16. doi: 10.1016/j.micinf.2011.10.00122033148
34. Hwang SA, Welsh KJ, Kruzel ML, Actor JK, Lactoferrin Augmentation of the BCG Vaccine Leads to Increased Pulmonary Integrity. Tuberc Res Treat. 2011;2011:835410. doi: 10.1155/2011/83541022567270
35. Cassidy JP, Martineau AR, Innate resistance to tuberculosis in man, cattle and laboratory animal models: nipping disease in the bud?J Comp Pathol. 2014; 151:291–308. doi: 10.1016/j.jcpa.2014.08.00125246179
36. Sharma P, Dube D, Sinha M, Yadav S, Kaur P, Sharma S, et al. Structural insights into the dual strategy of recognition by peptidoglycan recognition protein, PGRP-S: structure of the ternary complex of PGRP-S with lipopolysaccharide and stearic acid. PLoS One. 2013;8:e53756. doi: 10.1371/journal.pone.005375623326499
37. Mir SA, Sharma S, Role of MHC class Ib molecule, H2-M3 in host immunity against tuberculosis. Vaccine. 2013; 31:3818–25. doi: 10.1016/j.vaccine.2013.04.00523628242
38. Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, Kremer K, et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet. 2010;42:498–503. doi: 10.1038/ng.59020495566
39. Carpenter S, Ricci EP, Mercier BC, Moore MJ, Fitzgerald KA, Post-transcriptional regulation of gene expression in innate immunity. Nat Rev Immunol. 2014; 14:361–76. doi: 10.1038/nri368224854588
40. Piccirillo CA, Bjur E, Topisirovic I, Sonenberg N, Larsson O, Translational control of immune responses: from transcripts to translatomes. Nat Immunol. 2014;15:503–11. doi: 10.1038/ni.289124840981
41. Baynes RD, Flax H, Bothwell TH, Bezwoda WR, Atkinson P, Mendelow B, Red blood cell distribution width in the anemia secondary to tuberculosis. Am J Clin Pathol. 1986;85:226–9. 3946306
42. García-Jiménez WL, Benítez-Medina JM, Fernández-Llario P, Abecia JA, García-Sánchez A, Martínez R, et al. Comparative pathology of the natural infections by Mycobacterium bovis and by Mycobacterium caprae in wild boar (Sus scrofa). Transbound Emerg Dis. 2013;60:102–9. doi: 10.1111/j.1865-1682.2012.01321.x22469036
43. de la Fuente J, Estrada-Peña A, Cabezas-Cruz A, Kocan KM, Anaplasma phagocytophilum uses common strategies for infection of ticks and vertebrate hosts. Trends Microbiol. 2016; in press. doi: 10.1016/j.tim.2015.12.001
44. de la Fuente J, Gortázar C, Juste R, Complement component 3: a new paradigm in tuberculosis vaccine. Exp Rev Vaccines. 2016; in press. doi: 10.1586/14760584.2016.1125294